CEDENT
Principal Associate Scientist (Analytical Development)
CEDENT, Waltham, Massachusetts, United States, 02254
Responsibilities:Execute, develop, and optimize molecular assays for characterizing and testing viral vectors (Lentiviral vector, AAV), cell, and gene therapy products, in collaboration with the Elevatebio Analytical Testing Core and QC team.Work with AD SMEs, Analytical Testing Core, and QC teams to create and refine protocols, reports, and other technical documents for method development and optimization.Troubleshoot and address challenges during qualification and method transfer activities with key stakeholders.Support assay development and lifecycle management, incorporating new ideas and technologies as needed.Assist in investigations related to deviations during assay qualification or validation.Analyze, interpret, and present assay data during team meetings.Collaborate effectively with internal teams in Analytical Development, Quality, and external vendors.
Required Qualifications:BS in Cell Biology, Molecular Biology, Biochemistry, or related field with 6+ years of relevant experience, or MS with 4+ years of experience in a biotech setting.Experience in the development and qualification of analytical methods for QC GMP labs is preferred.Knowledge of ICH guidelines for method development/qualification is desirable.Expertise in molecular technologies such as ddPCR, qPCR, and ELISA.Familiarity with cell and gene therapy (CGT) products and viral vectors (Lentivirus, AAV) is a plus.Strong writing and communication skills, with experience in authoring and reviewing protocols and technical reports.Excellent organizational and multitasking abilities, with experience working in a cross-functional team environment.
#J-18808-Ljbffr
Required Qualifications:BS in Cell Biology, Molecular Biology, Biochemistry, or related field with 6+ years of relevant experience, or MS with 4+ years of experience in a biotech setting.Experience in the development and qualification of analytical methods for QC GMP labs is preferred.Knowledge of ICH guidelines for method development/qualification is desirable.Expertise in molecular technologies such as ddPCR, qPCR, and ELISA.Familiarity with cell and gene therapy (CGT) products and viral vectors (Lentivirus, AAV) is a plus.Strong writing and communication skills, with experience in authoring and reviewing protocols and technical reports.Excellent organizational and multitasking abilities, with experience working in a cross-functional team environment.
#J-18808-Ljbffr